找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Cannabinoids and Pain; Samer N. Narouze Book 2021 Springer Nature Switzerland AG 2021 Cannabis.Medical Marijuana.Cannabinoids.Endocannabin

[復(fù)制鏈接]
樓主: 劉興旺
11#
發(fā)表于 2025-3-23 09:41:45 | 只看該作者
Other Phytocannabinoidsiol (CBD) and Δ9-tetrahydrocannabinol (Δ9-THC). Endocannabinoids are endogenous chemicals which act on the cannabinoid receptors (CBR). Synthetic medications such as nabilone, dronabinol, and rimonabant are also commercially available..The phytocannabinoids are chemicals extracted from the cannabis
12#
發(fā)表于 2025-3-23 17:01:54 | 只看該作者
13#
發(fā)表于 2025-3-23 20:12:35 | 只看該作者
Dronabinol (Marinol?)ith weight loss in patients with AIDS and nausea and vomiting associated with cancer chemotherapy..Although it is not FDA approved for pain control, there are few reports suggesting its potential role in cancer pain, noncancer pain, neuropathic pain, and central pain.
14#
發(fā)表于 2025-3-23 23:00:33 | 只看該作者
Nabilone (Cesamet)n cannabinoids and synthetic analogues led to the development of nabilone, a Δ.-tetrahydrocannabinol (Δ.-THC) analogue. Numerous studies demonstrated nabilone’s superiority over older antiemetics, and while it was initially set for FDA approval in 1985 by Eli Lilly and Company, it was not until 2006
15#
發(fā)表于 2025-3-24 06:07:01 | 只看該作者
Cannabidiol (Epidiolex)sychotropic effects of the other well-known cannabinoid, Δ.-tetrahydrocannabinol. Lennox-Gastaut syndrome (LGS) and Dravet syndrome (DS) are two treatment-resistant seizure disorders for which alternative medications have been sought. Greenwich Biosciences developed a pharmaceutical grade liquid CBD
16#
發(fā)表于 2025-3-24 10:28:20 | 只看該作者
17#
發(fā)表于 2025-3-24 13:47:22 | 只看該作者
Book 2021edical cannabis utilization and provides recommendations for research and future directions..Organized into nine sections, the book begins with an introduction to medical cannabis, including its history, regulations, and the general attitudes of pain physicians on cannabis. Section two explores the
18#
發(fā)表于 2025-3-24 16:11:43 | 只看該作者
19#
發(fā)表于 2025-3-24 21:02:07 | 只看該作者
20#
發(fā)表于 2025-3-25 03:09:36 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-12 22:14
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
呼玛县| 大安市| 织金县| 东城区| 河源市| 新建县| 宁武县| 寿宁县| 炉霍县| 关岭| 宁德市| 淅川县| 甘孜| 黔南| 阜康市| 巍山| 冕宁县| 神农架林区| 凌源市| 台东市| 泽州县| 武定县| 新野县| 苗栗县| 商南县| 双峰县| 沛县| 囊谦县| 濮阳县| 吉木萨尔县| 安岳县| 丽水市| 独山县| 阿拉善右旗| 富源县| 镇安县| 万全县| 六安市| 遂溪县| 昌黎县| 徐汇区|